Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

Psoriatic arthritis is a type of arthritis that develops in some people who have psoriasis, which is a chronic autoimmune disease of the skin. Psoriatic arthritis can be mild or severe. It can also be ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Approximately 20% to 30% of all people who suffer from psoriasis also develop painful inflammation in their joints over time.

Psoriatic arthritis (PsA) causes your immune system to attack your joints, but it can also affect many other parts of your body. PsA usually comes alongside psoriasis, a similar long-term, ...

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

People with psoriatic arthritis face many challenges. The first one may be in learning that they have psoriatic arthritis. The diagnosis process can be difficult. For many, there may be a delay to ...

Jan 8 () - Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with ​its psoriatic ...

Medically reviewed by Stella Bard, MD Key Takeaways Osteoarthritis often starts on one side of the body and can spread to ...

Psoriatic arthritis is an autoimmune condition that causes joint inflammation, skin symptoms, and pain. People searching for psoriatic arthritis prescriptions are often looking for detailed ...

Share on Pinterest According to findings from a phase 2 clinical trial, brepocitinib may be an effective new medication to treat psoriatic arthrits. AsiaVision/Getty Images A new clinical trial shows ...